Key result
Endoscopic mitral valve repair demonstrated a 97.3% 5-year survival and 94.5% freedom from significant mitral regurgitation or reoperation, with no significant difference in outcomes between posterior leaflet resection and neochord implantation (p=0.63).
Why the study?
Although minimally invasive mitral valve repair adoption is increasing with satisfactory short-term results, mid-term outcomes and comparative data between leaflet resection and neochord implantation for posterior prolapse required evaluation.
Does posterior leaflet resection compared to neochord implantation improve mortality and recurrence of significant mitral regurgitation in patients undergoing endoscopic mitral valve repair for posterior leaflet prolapse?
Cohort (n=309)
No
Does posterior leaflet resection compared to neochord implantation improve mortality and recurrence of significant mitral regurgitation in patients undergoing endoscopic mitral valve repair for posterior leaflet prolapse?
Endoscopic mitral valve repair for posterior prolapse yields excellent mid-term outcomes, with no significant difference in efficacy between leaflet resection and neochord implantation.
Supports endoscopic repair durability for posterior prolapse; leaves open resection versus neochord choice pending randomized data.
BACKGROUND: The adoption of minimally invasive techniques to perform mitral valve repair surgery is increasing. This is enhanced by the compelling evidence of satisfactory short-term results and lower major morbidity. We analyzed mid-term follow-up results of our experience, and further compared two techniques: isolated leaflet resection and neochord implantation for posterior leaflet prolapse. METHODS: Data for all consecutive endoscopic mitral valve repairs via video-assisted right anterior mini-thoracotomy were analyzed between December 2012 and September 2021. The early and mid-term follow-up results were ascertained. The main outcome was the incidence of mortality and the recurrence of significant mitral regurgitation during follow-up which were summarized by the Kaplan-Meier estimator and compared between treatment arms using the stratified log-rank test. Secondary outcomes were the early-postoperative results including 30-days mortality and the occurrence of major complications. RESULTS: A total of 309 patients were included. Along with ring annuloplasty, 136 (44.4%) patients received posterior leaflet resection (122 isolated) whereas 97 (31.1%) underwent posterior leaflet chords implantation (88 isolated). Forty-nine patients had annuloplasty alone. In-hospital mortality was 1.0%. Mean follow-up was 28.8 ± 22.0 months (maximum 8.3 years). Kaplan-Meier survival rate at 5 years was 97.3 ± 1.0%, mitral regurgitation ([Formula: see text]3+) or valve reoperation free-survival at 5 years was estimated as 94.5 ± 2.3%. Subgroup time-to-event analysis for the indexed outcomes showed no statistical significance between the techniques. CONCLUSIONS: Endoscopic mitral valve repair is safe and associated with excellent short- and mid-term outcomes. No differences were found between leaflet resection and gore-tex chords implantation for posterior leaflet prolapse.
No takes yet. Share an insight, caveat, or question.
Squiccimarro et al. (2023) conducted a cohort in Mitral valve disease requiring repair (n=309). Posterior leaflet resection vs. Neochord implantation was evaluated on Incidence of mortality and recurrence of significant mitral regurgitation during follow-up (p=0.63). Endoscopic mitral valve repair demonstrated a 97.3% 5-year survival and 94.5% freedom from significant mitral regurgitation or reoperation, with no significant difference in outcomes between posterior leaflet resection and neochord implantation (p=0.63).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: